TREAT-NMD related projects
The European Commission made rare diseases one of its priorities for funding in 2012, with a major financial commitment to rare disease topics contributing towards the new International Rare Disease Research Consortium (IRDiRC) goals. Several groups with a neuromuscular interest took up the challenge of submitting applications to the FP7-HEALTH-2012-INNOVATION-1 call. We are delighted to report that a number of proposals involving TREAT-NMD participants have been successful and the following projects have now started.
COST (European Cooperation in Science and Technology) is one of the longest-running European frameworks supporting cooperation among scientists and researchers across Europe. The following projects have been successful in securing funds to develop cooperation further.
The European Commission's Directorate General for Health and Consumer Protection (DG SANCO) was established in 1999. The overall mission for DG SANCO is: “Together with the Member States, the European Union aims to protect and promote the health of its citizens.” It aims to improve quality of life in the EU through policies, laws and programmes in its three main areas of activity; public health, food safety and consumer protection.
Funded by NIHR and sponsored by Newcastle upon Tyne Hospitals NHS Foundation Trust.
Genzyme, Kurt + Peter foundation, LGMD2D, LGMD2iFund, Samantha J Brazzo Foundation and Ultragenyx fund MYO-SEQ.